.- per share 20,000,000.00 20,000,000.00 20,000,000.00 Accumulated profit (loss) 16,072,910.02 20,380,301.25 31,000,538.03 Total shareholders' equity 36,072,910.02 40,380,301.25 51,000,538.03 Total
Company encounters the situation of the lack of financial liquidity and the cash flow for debt repayment and business operation, as the Company has continuous loss. Thus, the Company considers the business
business operation, as the Company has continuous loss. Thus, the Company considers the business restructure of the Company’s group in order to cope with consequences from the current economic recession
27.46 38.56 (11.10) (28.79) Net Profit (Loss) (41.80) (83.80) 42.00 50.12 Earnings per share (Baht per share) (0.0092) (0.0185) 0.0093 50.27 Net Profit The company and subsidiaries realized net loss of
Expenses 27.46 38.55 (11.09) (28.77) Net Profit (Loss) (41.80) (83.80) 42.00 50.12 Earnings per share (Baht per share) (0.0092) (0.0185) 0.0093 50.27 Net Profit The company and subsidiaries realized net loss
government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is
UNOFFICIAL TRANSLATION Codified up to No. 2 As of 29 June 2012 Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference
granting of a short term loan, amounting THB 340,000,000 (three hundred and forty million baht only) with the term of loan for 6 months with an extension right for another 6 months, totally not exceeding the